European Medicines Agency uncertainty bad for patients and UK staff

Responding to the news that the European Medicines Agency  has issued a tender for temporary workers to deal with loss of staff as they prepare to leave London after Brexit, Lib Dem Brexit spokesman Tom Brake said: 

"It is clear that uncertainty over where the European Medicines Agency will be based in the future, as well as being damaging for UK science which will lose hundreds of highly qualified medical professionals to Amsterdam or another European capital, is hurting the Agency.

"They are having to work much harder to hold on to staff here as the agency prepares to leave the UK. This is bad for patients and the roll out of new innovative drugs. The damage caused to the EMA is another reason to allow the British people a vote on the terms of the deal, offering an exit from Brexit if that is what the people decide."